The following 3,464 ICD-10-CM codes contain 'Type 1 Excludes' annotation references within one-to-many other ICD-10-CM codes.
-
C92.10: C92.0
2023 ICD-10-CM Diagnosis Code C92.0
Acute myeloblastic leukemia
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Applicable To- Acute myeloblastic leukemia, minimal differentiation
- Acute myeloblastic leukemia (with maturation)
- Acute myeloblastic leukemia 1/ETO
- Acute myeloblastic leukemia M0
- Acute myeloblastic leukemia M1
- Acute myeloblastic leukemia M2
- Acute myeloblastic leukemia with t(8;21)
- Acute myeloblastic leukemia (without a FAB classification) NOS
- Refractory anemia with excess blasts in transformation [RAEB T]
Type 1 Excludes- acute exacerbation of chronic myeloid leukemia (C92.10)
- refractory anemia with excess of blasts not in transformation (D46.2-)
-
C92.2: C92.1, D47.1
2023 ICD-10-CM Diagnosis Code C92.1
Chronic myeloid leukemia, BCR/ABL-positive
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Applicable To- Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
- Chronic myelogenous leukemia, t(9;22) (q34;q11)
- Chronic myelogenous leukemia with crisis of blast cells
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myelomonocytic leukemia (C93.1-)
- chronic myeloproliferative disease (D47.1)
2023 ICD-10-CM Diagnosis Code D47.1
Chronic myeloproliferative disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
-
C93: D72.825
2023 ICD-10-CM Diagnosis Code D72.825
Bandemia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Bandemia without diagnosis of specific infection
-
C93.1: C92.1, D46.Z
2023 ICD-10-CM Diagnosis Code D46.Z
Other myelodysplastic syndromes
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Type 1 Excludes- chronic myelomonocytic leukemia (C93.1-)
2023 ICD-10-CM Diagnosis Code C92.1
Chronic myeloid leukemia, BCR/ABL-positive
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Applicable To- Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
- Chronic myelogenous leukemia, t(9;22) (q34;q11)
- Chronic myelogenous leukemia with crisis of blast cells
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myelomonocytic leukemia (C93.1-)
- chronic myeloproliferative disease (D47.1)
-
C94: D72.825
2023 ICD-10-CM Diagnosis Code D72.825
Bandemia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Bandemia without diagnosis of specific infection
-
C94.0: D53.1, D64.4
2023 ICD-10-CM Diagnosis Code D64.4
Congenital dyserythropoietic anemia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Dyshematopoietic anemia (congenital)
Type 1 Excludes- Blackfan-Diamond syndrome (D61.01)
- Di Guglielmo's disease (C94.0)
2023 ICD-10-CM Diagnosis Code D53.1
Other megaloblastic anemias, not elsewhere classified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Type 1 Excludes- Di Guglielmo's disease (C94.0)
-
C94.3: D47.02, D89.4
2023 ICD-10-CM Diagnosis Code D47.02
Systemic mastocytosis
2018 - New Code 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Indolent systemic mastocytosis
- Isolated bone marrow mastocytosis
- Smoldering systemic mastocytosis
- Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Code Also- , if applicable, any associated hematological non-mast cell lineage disease, such as:
- acute myeloid leukemia (C92.6-, C92.A-)
- chronic myelomonocytic leukemia (C93.1-)
- essential thrombocytosis (D47.3)
- hypereosinophilic syndrome (D72.1)
- myelodysplastic syndrome (D46.9)
- myeloproliferative syndrome (D47.1)
- non-Hodgkin lymphoma (C82-C85)
- plasma cell myeloma (C90.0-)
- polycythemia vera (D45)
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- mast cell leukemia (C94.3-)
2023 ICD-10-CM Diagnosis Code D89.4
Mast cell activation syndrome and related disorders
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
-
C94.30: C96.2
2023 ICD-10-CM Diagnosis Code C96.2
Malignant mast cell neoplasm
2016 2017 2018 - Converted to Parent Code 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- indolent mastocytosis (D47.02)
- mast cell leukemia (C94.30)
- mastocytosis (congenital) (cutaneous) (Q82.2)
-
C94.4: D47.4, D75.81
2023 ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
2023 ICD-10-CM Diagnosis Code D47.4
Osteomyelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic idiopathic myelofibrosis
- Myelofibrosis (idiopathic) (with myeloid metaplasia)
- Myelosclerosis (megakaryocytic) with myeloid metaplasia
- Secondary myelofibrosis in myeloproliferative disease
-
C95: D72.825
2023 ICD-10-CM Diagnosis Code D72.825
Bandemia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Bandemia without diagnosis of specific infection
-
C95.10: C95.0
2023 ICD-10-CM Diagnosis Code C95.0
Acute leukemia of unspecified cell type
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Applicable To- Acute bilineal leukemia
- Acute mixed lineage leukemia
- Biphenotypic acute leukemia
- Stem cell leukemia of unclear lineage
Type 1 Excludes- acute exacerbation of unspecified chronic leukemia (C95.10)
-
C95.9: Z85.6
2023 ICD-10-CM Diagnosis Code Z85.6
Personal history of leukemia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Conditions classifiable to C91-C95
-
C96: C77
2023 ICD-10-CM Diagnosis Code C77
Secondary and unspecified malignant neoplasm of lymph nodes
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
- mesentary metastasis of carcinoid tumor (C7B.04)
- secondary carcinoid tumors of distant lymph nodes (C7B.01)
-
C96.0: C96.5, C96.6, D76, D76
2023 ICD-10-CM Diagnosis Code C96.5
Multifocal and unisystemic Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Hand-Schüller-Christian disease
- Histiocytosis X, multifocal
Type 1 Excludes- multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis (C96.0)
- unifocal Langerhans-cell histiocytosis (C96.6)
2023 ICD-10-CM Diagnosis Code C96.6
Unifocal Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Eosinophilic granuloma
- Histiocytosis X, unifocal
- Histiocytosis X NOS
- Langerhans-cell histiocytosis NOS
Type 1 Excludes- multifocal and multisysemic (disseminated) Langerhans-cell histiocytosis (C96.0)
- multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
-
C96.2: D47.0, D89.4, Q82.2
2023 ICD-10-CM Diagnosis Code D89.4
Mast cell activation syndrome and related disorders
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
2023 ICD-10-CM Diagnosis Code Q82.2
Congenital cutaneous mastocytosis
2016 2017 2018 - Revised Code 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Congenital diffuse cutaneous mastocytosis
- Congenital maculopapular cutaneous mastocytosis
- Congenital urticaria pigmentosa
Type 1 Excludes- cutaneous mastocytosis NOS (D47.01)
- diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
- malignant mastocytosis (C96.2-)
- systemic mastocytosis (D47.02)
- urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
2023 ICD-10-CM Diagnosis Code D47.0
Mast cell neoplasms of uncertain behavior
2016 2017 2018 - Converted to Parent Code 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- congenital cutaneous mastocytosis (Q82.2)
- histiocytic neoplasms of uncertain behavior (D47.Z9)
- malignant mast cell neoplasm (C96.2-)
-
C96.21: D47.02, D89.4
2023 ICD-10-CM Diagnosis Code D47.02
Systemic mastocytosis
2018 - New Code 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Indolent systemic mastocytosis
- Isolated bone marrow mastocytosis
- Smoldering systemic mastocytosis
- Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Code Also- , if applicable, any associated hematological non-mast cell lineage disease, such as:
- acute myeloid leukemia (C92.6-, C92.A-)
- chronic myelomonocytic leukemia (C93.1-)
- essential thrombocytosis (D47.3)
- hypereosinophilic syndrome (D72.1)
- myelodysplastic syndrome (D46.9)
- myeloproliferative syndrome (D47.1)
- non-Hodgkin lymphoma (C82-C85)
- plasma cell myeloma (C90.0-)
- polycythemia vera (D45)
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- mast cell leukemia (C94.3-)
2023 ICD-10-CM Diagnosis Code D89.4
Mast cell activation syndrome and related disorders
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
-
C96.22: D89.4
2023 ICD-10-CM Diagnosis Code D89.4
Mast cell activation syndrome and related disorders
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
-
C96.29: D89.4
2023 ICD-10-CM Diagnosis Code D89.4
Mast cell activation syndrome and related disorders
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
-
C96.5: C96.0, C96.6, D76, D76, D76
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code C96.6
Unifocal Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Eosinophilic granuloma
- Histiocytosis X, unifocal
- Histiocytosis X NOS
- Langerhans-cell histiocytosis NOS
Type 1 Excludes- multifocal and multisysemic (disseminated) Langerhans-cell histiocytosis (C96.0)
- multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
2023 ICD-10-CM Diagnosis Code C96.0
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Histiocytosis X, multisystemic
- Letterer-Siwe disease
Type 1 Excludes- adult pulmonary Langerhans cell histiocytosis (J84.82)
- multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
- unifocal Langerhans-cell histiocytosis (C96.6)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
-
C96.6: C96.0, C96.5, D76, D76, D76, D76, E88
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code C96.0
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Histiocytosis X, multisystemic
- Letterer-Siwe disease
Type 1 Excludes- adult pulmonary Langerhans cell histiocytosis (J84.82)
- multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
- unifocal Langerhans-cell histiocytosis (C96.6)
2023 ICD-10-CM Diagnosis Code C96.5
Multifocal and unisystemic Langerhans-cell histiocytosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Hand-Schüller-Christian disease
- Histiocytosis X, multifocal
Type 1 Excludes- multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis (C96.0)
- unifocal Langerhans-cell histiocytosis (C96.6)
2023 ICD-10-CM Diagnosis Code E88
Other and unspecified metabolic disorders
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- histiocytosis X (chronic) (C96.6)
Use Additional- codes for associated conditions
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
-
C96.9: D76
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
-
C96.A: D76, D76
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
2023 ICD-10-CM Diagnosis Code D76
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- (Abt-) Letterer-Siwe disease (C96.0)
- eosinophilic granuloma (C96.6)
- Hand-Schüller-Christian disease (C96.5)
- histiocytic medullary reticulosis (C96.9)
- histiocytic sarcoma (C96.A)
- histiocytosis X, multifocal (C96.5)
- histiocytosis X, unifocal (C96.6)
- Langerhans-cell histiocytosis, multifocal (C96.5)
- Langerhans-cell histiocytosis NOS (C96.6)
- Langerhans-cell histiocytosis, unifocal (C96.6)
- leukemic reticuloendotheliosis (C91.4-)
- lipomelanotic reticulosis (I89.8)
- malignant histiocytosis (C96.A)
- malignant reticulosis (C86.0)
- nonlipid reticuloendotheliosis (C96.0)
-
D00.0: K13.2
2023 ICD-10-CM Diagnosis Code K13.2
Leukoplakia and other disturbances of oral epithelium, including tongue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of oral epithelium (D00.0-)
- hairy leukoplakia (K13.3)
-
D00.08: D02.0, D02.0, D02.0
2023 ICD-10-CM Diagnosis Code D02.0
Carcinoma in situ of larynx
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
- Carcinoma in situ of epiglottis (suprahyoid portion)
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
- carcinoma in situ of hypopharyngeal aspect (D00.08)
- carcinoma in situ of marginal zone (D00.08)
2023 ICD-10-CM Diagnosis Code D02.0
Carcinoma in situ of larynx
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
- Carcinoma in situ of epiglottis (suprahyoid portion)
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
- carcinoma in situ of hypopharyngeal aspect (D00.08)
- carcinoma in situ of marginal zone (D00.08)
2023 ICD-10-CM Diagnosis Code D02.0
Carcinoma in situ of larynx
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
- Carcinoma in situ of epiglottis (suprahyoid portion)
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
- carcinoma in situ of hypopharyngeal aspect (D00.08)
- carcinoma in situ of marginal zone (D00.08)
-
D01.1: D01.0
2023 ICD-10-CM Diagnosis Code D01.0
Carcinoma in situ of colon
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Type 1 Excludes- carcinoma in situ of rectosigmoid junction (D01.1)
-
D01.3: D04.5, K62.82, K62.82, K62.82, R85.61, R85.61, R85.61
2023 ICD-10-CM Diagnosis Code D04.5
Carcinoma in situ of skin of trunk
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of anal margin
- Carcinoma in situ of anal skin
- Carcinoma in situ of perianal skin
- Carcinoma in situ of skin of breast
Type 1 Excludes- carcinoma in situ of anus NOS (D01.3)
- carcinoma in situ of scrotum (D07.61)
- carcinoma in situ of skin of genital organs (D07.-)
2023 ICD-10-CM Diagnosis Code K62.82
Dysplasia of anus
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
- Dysplasia of anus NOS
- Mild and moderate dysplasia of anus (histologically confirmed)
Type 1 Excludes- abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
- anal intraepithelial neoplasia III (D01.3)
- carcinoma in situ of anus (D01.3)
- HGSIL of anus (R85.613)
- severe dysplasia of anus (D01.3)
2023 ICD-10-CM Diagnosis Code K62.82
Dysplasia of anus
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
- Dysplasia of anus NOS
- Mild and moderate dysplasia of anus (histologically confirmed)
Type 1 Excludes- abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
- anal intraepithelial neoplasia III (D01.3)
- carcinoma in situ of anus (D01.3)
- HGSIL of anus (R85.613)
- severe dysplasia of anus (D01.3)
2023 ICD-10-CM Diagnosis Code K62.82
Dysplasia of anus
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
- Dysplasia of anus NOS
- Mild and moderate dysplasia of anus (histologically confirmed)
Type 1 Excludes- abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
- anal intraepithelial neoplasia III (D01.3)
- carcinoma in situ of anus (D01.3)
- HGSIL of anus (R85.613)
- severe dysplasia of anus (D01.3)
2023 ICD-10-CM Diagnosis Code R85.61
Abnormal cytologic smear of anus
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
- carcinoma in situ of anus (histologically confirmed) (D01.3)
- anal intraepithelial neoplasia I [AIN I] (K62.82)
- anal intraepithelial neoplasia II [AIN II] (K62.82)
- anal intraepithelial neoplasia III [AIN III] (D01.3)
- dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
- severe dysplasia of anus (histologically confirmed) (D01.3)
Type 2 Excludes- anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
- anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
2023 ICD-10-CM Diagnosis Code R85.61
Abnormal cytologic smear of anus
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
- carcinoma in situ of anus (histologically confirmed) (D01.3)
- anal intraepithelial neoplasia I [AIN I] (K62.82)
- anal intraepithelial neoplasia II [AIN II] (K62.82)
- anal intraepithelial neoplasia III [AIN III] (D01.3)
- dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
- severe dysplasia of anus (histologically confirmed) (D01.3)
Type 2 Excludes- anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
- anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
2023 ICD-10-CM Diagnosis Code R85.61
Abnormal cytologic smear of anus
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
- carcinoma in situ of anus (histologically confirmed) (D01.3)
- anal intraepithelial neoplasia I [AIN I] (K62.82)
- anal intraepithelial neoplasia II [AIN II] (K62.82)
- anal intraepithelial neoplasia III [AIN III] (D01.3)
- dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
- severe dysplasia of anus (histologically confirmed) (D01.3)
Type 2 Excludes- anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
- anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
-
D01.5: D01.4
2023 ICD-10-CM Diagnosis Code D01.4
Carcinoma in situ of other and unspecified parts of intestine
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of ampulla of Vater (D01.5)
-
D01.7: D09.3
2023 ICD-10-CM Diagnosis Code D09.3
Carcinoma in situ of thyroid and other endocrine glands
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Type 1 Excludes- carcinoma in situ of endocrine pancreas (D01.7)
- carcinoma in situ of ovary (D07.39)
- carcinoma in situ of testis (D07.69)
-
D02.0: D00.0, D00.0, D00.0
2023 ICD-10-CM Diagnosis Code D00.0
Carcinoma in situ of lip, oral cavity and pharynx
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
2023 ICD-10-CM Diagnosis Code D00.0
Carcinoma in situ of lip, oral cavity and pharynx
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
2023 ICD-10-CM Diagnosis Code D00.0
Carcinoma in situ of lip, oral cavity and pharynx
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
-
D03: C43, D00, D01, D02, D04, D09
2023 ICD-10-CM Diagnosis Code D09
Carcinoma in situ of other and unspecified sites
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
2023 ICD-10-CM Diagnosis Code D04
Carcinoma in situ of skin
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- erythroplasia of Queyrat (penis) NOS (D07.4)
- melanoma in situ (D03.-)
2023 ICD-10-CM Diagnosis Code D00
Carcinoma in situ of oral cavity, esophagus and stomach
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
2023 ICD-10-CM Diagnosis Code D01
Carcinoma in situ of other and unspecified digestive organs
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
2023 ICD-10-CM Diagnosis Code D02
Carcinoma in situ of middle ear and respiratory system
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
2023 ICD-10-CM Diagnosis Code C43
Malignant melanoma of skin
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 2 Excludes- malignant melanoma of skin of genital organs (C51-C52, C60.-, C63.-)
- Merkel cell carcinoma (C4A.-)
- sites other than skin-code to malignant neoplasm of the site
-
D03.0: D00.0
2023 ICD-10-CM Diagnosis Code D00.0
Carcinoma in situ of lip, oral cavity and pharynx
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
-
D03.5: D05, D06, D07
2023 ICD-10-CM Diagnosis Code D06
Carcinoma in situ of cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Includes- cervical adenocarcinoma in situ
- cervical intraepithelial glandular neoplasia
- cervical intraepithelial neoplasia III [CIN III]
- severe dysplasia of cervix uteri
Type 1 Excludes- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cytologic evidence of malignancy of cervix without histologic confirmation (R87.614)
- high grade squamous intraepithelial lesion (HGSIL) of cervix (R87.613)
- melanoma in situ of cervix (D03.5)
- moderate cervical dysplasia (N87.1)
2023 ICD-10-CM Diagnosis Code D07
Carcinoma in situ of other and unspecified genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- melanoma in situ of trunk (D03.5)
2023 ICD-10-CM Diagnosis Code D05
Carcinoma in situ of breast
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of skin of breast (D04.5)
- melanoma in situ of breast (skin) (D03.5)
- Paget's disease of breast or nipple (C50.-)
-
D04.0: D00.0
2023 ICD-10-CM Diagnosis Code D00.0
Carcinoma in situ of lip, oral cavity and pharynx
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
Use Additional- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
-
D04.1: D09.2
2023 ICD-10-CM Diagnosis Code D09.2
Carcinoma in situ of eye
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of skin of eyelid (D04.1-)
-
D04.2: D02.3
2023 ICD-10-CM Diagnosis Code D02.3
Carcinoma in situ of other parts of respiratory system
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of accessory sinuses
- Carcinoma in situ of middle ear
- Carcinoma in situ of nasal cavities
Type 1 Excludes- carcinoma in situ of ear (external) (skin) (D04.2-)
- carcinoma in situ of nose NOS (D09.8)
- carcinoma in situ of skin of nose (D04.3)
-
D04.3: D02.3
2023 ICD-10-CM Diagnosis Code D02.3
Carcinoma in situ of other parts of respiratory system
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of accessory sinuses
- Carcinoma in situ of middle ear
- Carcinoma in situ of nasal cavities
Type 1 Excludes- carcinoma in situ of ear (external) (skin) (D04.2-)
- carcinoma in situ of nose NOS (D09.8)
- carcinoma in situ of skin of nose (D04.3)
-
D04.5: D01.3, D01.3, D01.3, D05
2023 ICD-10-CM Diagnosis Code D05
Carcinoma in situ of breast
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of skin of breast (D04.5)
- melanoma in situ of breast (skin) (D03.5)
- Paget's disease of breast or nipple (C50.-)
2023 ICD-10-CM Diagnosis Code D01.3
Carcinoma in situ of anus and anal canal
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia III [AIN III]
- Severe dysplasia of anus
Type 1 Excludes- anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
- carcinoma in situ of anal margin (D04.5)
- carcinoma in situ of anal skin (D04.5)
- carcinoma in situ of perianal skin (D04.5)
2023 ICD-10-CM Diagnosis Code D01.3
Carcinoma in situ of anus and anal canal
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia III [AIN III]
- Severe dysplasia of anus
Type 1 Excludes- anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
- carcinoma in situ of anal margin (D04.5)
- carcinoma in situ of anal skin (D04.5)
- carcinoma in situ of perianal skin (D04.5)
2023 ICD-10-CM Diagnosis Code D01.3
Carcinoma in situ of anus and anal canal
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Anal intraepithelial neoplasia III [AIN III]
- Severe dysplasia of anus
Type 1 Excludes- anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
- carcinoma in situ of anal margin (D04.5)
- carcinoma in situ of anal skin (D04.5)
- carcinoma in situ of perianal skin (D04.5)
-
D06: C53, N87, N87, N87, R87.61, R87.61, R87.61, R87.7, R87.7
2023 ICD-10-CM Diagnosis Code C53
Malignant neoplasm of cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of cervix uteri (D06.-)
2023 ICD-10-CM Diagnosis Code N87
Dysplasia of cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
- carcinoma in situ of cervix uteri (D06.-)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- HGSIL of cervix (R87.613)
- severe dysplasia of cervix uteri (D06.-)
2023 ICD-10-CM Diagnosis Code N87
Dysplasia of cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
- carcinoma in situ of cervix uteri (D06.-)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- HGSIL of cervix (R87.613)
- severe dysplasia of cervix uteri (D06.-)
2023 ICD-10-CM Diagnosis Code N87
Dysplasia of cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
- carcinoma in situ of cervix uteri (D06.-)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- HGSIL of cervix (R87.613)
- severe dysplasia of cervix uteri (D06.-)
2023 ICD-10-CM Diagnosis Code R87.61
Abnormal cytological findings in specimens from cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other female genital organs (R87.69)
- abnormal cytological findings in specimens from vagina (R87.62-)
- carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Type 2 Excludes- cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
- cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
2023 ICD-10-CM Diagnosis Code R87.61
Abnormal cytological findings in specimens from cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other female genital organs (R87.69)
- abnormal cytological findings in specimens from vagina (R87.62-)
- carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Type 2 Excludes- cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
- cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
2023 ICD-10-CM Diagnosis Code R87.61
Abnormal cytological findings in specimens from cervix uteri
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from other female genital organs (R87.69)
- abnormal cytological findings in specimens from vagina (R87.62-)
- carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Type 2 Excludes- cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
- cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
2023 ICD-10-CM Diagnosis Code R87.7
Abnormal histological findings in specimens from female genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
Type 1 Excludes- carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
2023 ICD-10-CM Diagnosis Code R87.7
Abnormal histological findings in specimens from female genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
Type 1 Excludes- carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
-
D07: D04.5
2023 ICD-10-CM Diagnosis Code D04.5
Carcinoma in situ of skin of trunk
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Carcinoma in situ of anal margin
- Carcinoma in situ of anal skin
- Carcinoma in situ of perianal skin
- Carcinoma in situ of skin of breast
Type 1 Excludes- carcinoma in situ of anus NOS (D01.3)
- carcinoma in situ of scrotum (D07.61)
- carcinoma in situ of skin of genital organs (D07.-)
-
D07.1: C51, N90, N90, N90
2023 ICD-10-CM Diagnosis Code C51
Malignant neoplasm of vulva
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- carcinoma in situ of vulva (D07.1)
2023 ICD-10-CM Diagnosis Code N90
Other noninflammatory disorders of vulva and perineum
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- anogenital (venereal) warts (A63.0)
- carcinoma in situ of vulva (D07.1)
- condyloma acuminatum (A63.0)
- current obstetric trauma (O70.-, O71.7-O71.8)
- inflammation of vulva (N76.-)
- severe dysplasia of vulva (D07.1)
- vulvar intraepithelial neoplasm III [VIN III] (D07.1)
2023 ICD-10-CM Diagnosis Code N90
Other noninflammatory disorders of vulva and perineum
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- anogenital (venereal) warts (A63.0)
- carcinoma in situ of vulva (D07.1)
- condyloma acuminatum (A63.0)
- current obstetric trauma (O70.-, O71.7-O71.8)
- inflammation of vulva (N76.-)
- severe dysplasia of vulva (D07.1)
- vulvar intraepithelial neoplasm III [VIN III] (D07.1)
2023 ICD-10-CM Diagnosis Code N90
Other noninflammatory disorders of vulva and perineum
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- anogenital (venereal) warts (A63.0)
- carcinoma in situ of vulva (D07.1)
- condyloma acuminatum (A63.0)
- current obstetric trauma (O70.-, O71.7-O71.8)
- inflammation of vulva (N76.-)
- severe dysplasia of vulva (D07.1)
- vulvar intraepithelial neoplasm III [VIN III] (D07.1)
-
D07.2: C52, N89, N89, N89, R87.62, R87.7, R87.7
2023 ICD-10-CM Diagnosis Code C52
Malignant neoplasm of vagina
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
Type 1 Excludes- carcinoma in situ of vagina (D07.2)
2023 ICD-10-CM Diagnosis Code N89
Other noninflammatory disorders of vagina
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
- carcinoma in situ of vagina (D07.2)
- HGSIL of vagina (R87.623)
- inflammation of vagina (N76.-)
- senile (atrophic) vaginitis (N95.2)
- severe dysplasia of vagina (D07.2)
- trichomonal leukorrhea (A59.00)
- vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
2023 ICD-10-CM Diagnosis Code N89
Other noninflammatory disorders of vagina
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
- carcinoma in situ of vagina (D07.2)
- HGSIL of vagina (R87.623)
- inflammation of vagina (N76.-)
- senile (atrophic) vaginitis (N95.2)
- severe dysplasia of vagina (D07.2)
- trichomonal leukorrhea (A59.00)
- vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
2023 ICD-10-CM Diagnosis Code N89
Other noninflammatory disorders of vagina
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
- carcinoma in situ of vagina (D07.2)
- HGSIL of vagina (R87.623)
- inflammation of vagina (N76.-)
- senile (atrophic) vaginitis (N95.2)
- severe dysplasia of vagina (D07.2)
- trichomonal leukorrhea (A59.00)
- vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
2023 ICD-10-CM Diagnosis Code R87.7
Abnormal histological findings in specimens from female genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
Type 1 Excludes- carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
2023 ICD-10-CM Diagnosis Code R87.7
Abnormal histological findings in specimens from female genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
Type 1 Excludes- carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
2023 ICD-10-CM Diagnosis Code R87.62
Abnormal cytological findings in specimens from vagina
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- abnormal cytological findings in specimens from cervix uteri (R87.61-)
- abnormal cytological findings in specimens from other female genital organs (R87.69)
- carcinoma in situ of vagina (histologically confirmed) (D07.2)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
Type 2 Excludes- vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
- vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
Use Additional- code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)